Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Eli Lilly And Co.filedCriticalEli Lilly And Co.
Priority to HU9902723ApriorityCriticalpatent/HUP9902723A3/hu
Publication of HUP9902723A2publicationCriticalpatent/HUP9902723A2/hu
Publication of HUP9902723A3publicationCriticalpatent/HUP9902723A3/hu
Pharmaceuticals Containing Other Organic And Inorganic Compounds
(AREA)
Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur
(AREA)
Abstract
A találmány tárgyát az (I) képletű őlanzapinnak, valamint II pőlimőrfmódősűlatának alkalmazása képezi migrénes fájdalőm kezelésére szőlgálógyógyszerkészítmény előállítása céljából. ŕ
HU9902723A1997-03-241997-03-24Use of olanzapine for the preparation of pharmaceutical compositions treating migraine pain
HUP9902723A3
(en)
The use of inhibitors of the renin-angiotensin system for producing pharmaceutical compositions using for the treatment of hypoxia or impaired metabolic function